BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7386284)

  • 1. Prostaglandin enhancement of skin tumor initiation and promotion.
    Fischer SM; Gleason GL; Bohrman JS; Slaga TJ
    Adv Prostaglandin Thromboxane Res; 1980; 6():517-22. PubMed ID: 7386284
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
    Verma AK; Ashendel CL; Boutwell RK
    Cancer Res; 1980 Feb; 40(2):308-15. PubMed ID: 6243250
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological effects of phorbol ester tumor promoters in mouse skin.
    Marks F; Fürstenberger G; Ganss M; Seemann D
    Prog Clin Biol Res; 1982; 102 pt A():243-59. PubMed ID: 7167438
    [No Abstract]   [Full Text] [Related]  

  • 4. Indomethacin enhancement of TPA tumor promotion in mice.
    Fischer SM; Gleason GL; Mills GD; Slaga TJ
    Cancer Lett; 1980 Oct; 10(4):343-50. PubMed ID: 7427927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandins and skin tumor promotion: inhibition of tumor promoter-induced ornithine decarboxylase activity in epidermis by inhibitors of prostaglandin synthesis.
    Verma AK; Rice HM; Boutwell RK
    Biochem Biophys Res Commun; 1977 Dec; 79(4):1160-6. PubMed ID: 414746
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of phorbol esters on basal epidermal cells derived from ear skin of adult guniea pigs.
    Delescluse C; Fürstenberger G; Marks F; Pruniéras M
    Cancer Res; 1982 May; 42(5):1975-9. PubMed ID: 6950814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal prostaglandins after topical application of a tumor promotor.
    Bresnick E; Meunier P; Lamden M
    Cancer Lett; 1979 Jul; 7(2-3):121-5. PubMed ID: 476606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the relationship between epidermal hyperproliferation and skin tumor promotion.
    Marks F; Berry DL; Bertsch S; Fürstenberger G; Richter H
    Carcinog Compr Surv; 1982; 7():331-46. PubMed ID: 6802490
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of plasminogen activator and prostaglandin biosynthesis in HeLa cells by 12-O-tetradecanoylphorbol-13-acetate.
    Crutchley DJ; Conanan LB; Maynard JR
    Cancer Res; 1980 Mar; 40(3):849-52. PubMed ID: 7193516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of butyric acid on tumor promotion: a correction.
    Belman S
    Cancer Res; 1981 Sep; 41(9 Pt 1):3669. PubMed ID: 7260921
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of 12-O-tetradecanoylphorbol-13-acetate on epithelial tumor induction in methylcholanthrene injected Swiss albino mice.
    Bhisey RA; Ramchandani AG; Sirsat SM; Borges A
    Indian J Exp Biol; 1983 Jun; 21(6):318-23. PubMed ID: 6667987
    [No Abstract]   [Full Text] [Related]  

  • 12. Indomethacin inhibition of cell proliferation induced by the phorbolester TPA is reversed by prostaglandin E2 in mouse epidermis in vivo.
    Fürstenberger G; Marks F
    Biochem Biophys Res Commun; 1978 Oct; 84(4):1103-11. PubMed ID: 728148
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted expression of human O(6)-methylguanine-DNA methyltransferase (MGMT) in transgenic mice protects against tumor initiation in two-stage skin carcinogenesis.
    Becker K; Dosch J; Gregel CM; Martin BA; Kaina B
    Cancer Res; 1996 Jul; 56(14):3244-9. PubMed ID: 8764116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effect of a tumor promoter, 12-O-tetradecanoylphorbol-13-acetate, on induced differentiation of Friend leukemia cells.
    Yamasaki H; Saint-Vincent L; Martel N
    Cancer Res; 1980 Oct; 40(10):3780-5. PubMed ID: 7438061
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of tumor promoters on arachidonic acid metabolism by cells in culture.
    Levine L
    Carcinog Compr Surv; 1982; 7():477-94. PubMed ID: 6802494
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of novel genetic loci contributing to 12-O-tetradecanoylphorbol-13-acetate skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.
    Angel JM; Caballero M; DiGiovanni J
    Cancer Res; 2003 Jun; 63(11):2747-51. PubMed ID: 12782578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical effect of anthralin on 12-O-tetradecanoylphorbol-13-acetate-induced mouse epidermal ornithine decarboxylase activity, proliferation, and tumor promotion.
    De Young LM; Helmes CT; Chao WR; Young JM; Miller V
    Cancer Res; 1981 Jan; 41(1):204-8. PubMed ID: 7448761
    [No Abstract]   [Full Text] [Related]  

  • 18. Acceleration of skin tumorigenesis in mice by submandibular and sublingual gland excision.
    O'Connell JF; Weiss HS; Pitt JF; Miller RE; Graff DE
    Carcinogenesis; 1983 Sep; 4(9):1197-9. PubMed ID: 6309426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative inhibitory activity of bile acids against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation, and chenodeoxycholic acid inhibition of tumour promotion in mouse skin two-stage carcinogenesis.
    Yasukawa K; Iida T; Fujimoto Y
    J Pharm Pharmacol; 2009 Aug; 61(8):1051-6. PubMed ID: 19703349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships in chick embryo fibroblasts for phorbol-related diterpene esters showing anomalous activities in vivo.
    Driedger PE; Blumberg PM
    Cancer Res; 1980 Feb; 40(2):339-46. PubMed ID: 7356517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.